Cargando…

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes

BACKGROUND: KRAS-mutated non-small cell lung cancer (NSCLC) accounts for 23–35% and 13–20% of all NSCLCs in white patients and East Asians, respectively, and is therefore regarded as a major therapeutic target. However, its epidemiology and clinical characteristics have not been fully elucidated bec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Koichi, Akamatsu, Hiroaki, Koh, Yasuhiro, Ogawa, Koichi, Isa, Shun-ichi, Ando, Masahiko, Tamiya, Akihiro, Kubo, Akihito, Kitagawa, Chiyoe, Kawaguchi, Tomoya, Yamamoto, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641926/
https://www.ncbi.nlm.nih.gov/pubmed/36348317
http://dx.doi.org/10.1186/s12885-022-10246-7
_version_ 1784826193003937792
author Sato, Koichi
Akamatsu, Hiroaki
Koh, Yasuhiro
Ogawa, Koichi
Isa, Shun-ichi
Ando, Masahiko
Tamiya, Akihiro
Kubo, Akihito
Kitagawa, Chiyoe
Kawaguchi, Tomoya
Yamamoto, Nobuyuki
author_facet Sato, Koichi
Akamatsu, Hiroaki
Koh, Yasuhiro
Ogawa, Koichi
Isa, Shun-ichi
Ando, Masahiko
Tamiya, Akihiro
Kubo, Akihito
Kitagawa, Chiyoe
Kawaguchi, Tomoya
Yamamoto, Nobuyuki
author_sort Sato, Koichi
collection PubMed
description BACKGROUND: KRAS-mutated non-small cell lung cancer (NSCLC) accounts for 23–35% and 13–20% of all NSCLCs in white patients and East Asians, respectively, and is therefore regarded as a major therapeutic target. However, its epidemiology and clinical characteristics have not been fully elucidated because of its wide variety of mutational subtypes. Here, we focused on two distinct base substitution types: transversion mutations and transition mutations, as well as their association with environmental factors and clinical outcome. METHODS: Dataset from the Japan Molecular Epidemiology Study, which is a prospective, multicenter, and molecular study epidemiology cohort study involving 957 NSCLC patients who underwent surgery, was used for this study. Questionnaire-based detailed information on clinical background and lifestyles was also used to assess their association with mutational subtypes. Somatic mutations in 72 cancer-related genes were analyzed by next-generation sequencing, and KRAS mutations were classified into three categories: transversions (G > C or G > T; G12A, G12C, G12R, G12V), transitions (G > A; G12D, G12S, G13D), and wild-type (WT). Clinical correlations between these subtypes have been investigated, and recurrence-free survival (RFS) and overall survival (OS) were evaluated. RESULTS: Of the 957 patients, KRAS mutations were detected in 80 (8.4%). Of these, 61 were transversions and 19 were transitions mutations. Both pack-years of smoking and smoking duration had significant positive correlation with the occurrence of transversion mutations (p = 0.03 and < 0.01, respectively). Notably, transitions showed an inverse correlation with vegetable intake (p = 0.01). Patients with KRAS transitions had the shortest RFS and OS compared to KRAS transversions and WT. Multivariate analysis revealed that KRAS transitions, along with age and stage, were significant predictors of shorter RFS and OS (HR 2.15, p = 0.01; and HR 2.84, p < 0.01, respectively). CONCLUSIONS: Smoking exposure positively correlated with transversions occurrence in a dose-dependent manner. However, vegetable intake negatively correlated with transitions. Overall, KRAS transition mutations are significantly poor prognostic factors among resected NSCLC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10246-7.
format Online
Article
Text
id pubmed-9641926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96419262022-11-15 Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes Sato, Koichi Akamatsu, Hiroaki Koh, Yasuhiro Ogawa, Koichi Isa, Shun-ichi Ando, Masahiko Tamiya, Akihiro Kubo, Akihito Kitagawa, Chiyoe Kawaguchi, Tomoya Yamamoto, Nobuyuki BMC Cancer Research BACKGROUND: KRAS-mutated non-small cell lung cancer (NSCLC) accounts for 23–35% and 13–20% of all NSCLCs in white patients and East Asians, respectively, and is therefore regarded as a major therapeutic target. However, its epidemiology and clinical characteristics have not been fully elucidated because of its wide variety of mutational subtypes. Here, we focused on two distinct base substitution types: transversion mutations and transition mutations, as well as their association with environmental factors and clinical outcome. METHODS: Dataset from the Japan Molecular Epidemiology Study, which is a prospective, multicenter, and molecular study epidemiology cohort study involving 957 NSCLC patients who underwent surgery, was used for this study. Questionnaire-based detailed information on clinical background and lifestyles was also used to assess their association with mutational subtypes. Somatic mutations in 72 cancer-related genes were analyzed by next-generation sequencing, and KRAS mutations were classified into three categories: transversions (G > C or G > T; G12A, G12C, G12R, G12V), transitions (G > A; G12D, G12S, G13D), and wild-type (WT). Clinical correlations between these subtypes have been investigated, and recurrence-free survival (RFS) and overall survival (OS) were evaluated. RESULTS: Of the 957 patients, KRAS mutations were detected in 80 (8.4%). Of these, 61 were transversions and 19 were transitions mutations. Both pack-years of smoking and smoking duration had significant positive correlation with the occurrence of transversion mutations (p = 0.03 and < 0.01, respectively). Notably, transitions showed an inverse correlation with vegetable intake (p = 0.01). Patients with KRAS transitions had the shortest RFS and OS compared to KRAS transversions and WT. Multivariate analysis revealed that KRAS transitions, along with age and stage, were significant predictors of shorter RFS and OS (HR 2.15, p = 0.01; and HR 2.84, p < 0.01, respectively). CONCLUSIONS: Smoking exposure positively correlated with transversions occurrence in a dose-dependent manner. However, vegetable intake negatively correlated with transitions. Overall, KRAS transition mutations are significantly poor prognostic factors among resected NSCLC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10246-7. BioMed Central 2022-11-08 /pmc/articles/PMC9641926/ /pubmed/36348317 http://dx.doi.org/10.1186/s12885-022-10246-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sato, Koichi
Akamatsu, Hiroaki
Koh, Yasuhiro
Ogawa, Koichi
Isa, Shun-ichi
Ando, Masahiko
Tamiya, Akihiro
Kubo, Akihito
Kitagawa, Chiyoe
Kawaguchi, Tomoya
Yamamoto, Nobuyuki
Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes
title Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes
title_full Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes
title_fullStr Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes
title_full_unstemmed Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes
title_short Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes
title_sort differential properties of kras transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641926/
https://www.ncbi.nlm.nih.gov/pubmed/36348317
http://dx.doi.org/10.1186/s12885-022-10246-7
work_keys_str_mv AT satokoichi differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT akamatsuhiroaki differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT kohyasuhiro differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT ogawakoichi differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT isashunichi differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT andomasahiko differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT tamiyaakihiro differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT kuboakihito differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT kitagawachiyoe differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT kawaguchitomoya differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes
AT yamamotonobuyuki differentialpropertiesofkrastransversionandtransitionmutationsinnonsmallcelllungcancerassociationswithenvironmentalfactorsandclinicaloutcomes